IWS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.200200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.710000E-01
Normal-vs-Stage2
7.890200E-01
Normal-vs-Stage3
6.753800E-01
Normal-vs-Stage4
1.472960E-01
Stage1-vs-Stage2
9.855800E-01
Stage1-vs-Stage3
4.490600E-01
Stage1-vs-Stage4
1.007580E-01
Stage2-vs-Stage3
3.369000E-01
Stage2-vs-Stage4
1.851840E-02
Stage3-vs-Stage4
9.535800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.885800E-01
Normal-vs-AfricanAmerican
7.890400E-01
Normal-vs-Asian
8.096800E-01
Caucasian-vs-AfricanAmerican
9.342800E-01
Caucasian-vs-Asian
2.969400E-01
AfricanAmerican-vs-Asian
5.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.454800E-01
Normal-vs-Female
9.228200E-01
Male-vs-Female
3.323000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.617200E-01
Normal-vs-Age(41-60Yrs)
4.646200E-01
Normal-vs-Age(61-80Yrs)
9.855200E-01
Normal-vs-Age(81-100Yrs)
7.127800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.288200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.275400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.186600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.345890E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.410600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.391200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.298400E-01
Normal-vs-Daily Drinker
5.859800E-01
Normal-vs-Weekly Drinker
6.218600E-01
Normal-vs-Occasional Drinker
3.521600E-01
Normal-vs-Social Drinker
8.582400E-01
Non Drinker-vs-Daily Drinker
3.891200E-01
Non Drinker-vs-Weekly Drinker
2.427800E-01
Non Drinker-vs-Occasional Drinker
1.018420E-01
Non Drinker-vs-Social Drinker
6.526400E-01
Daily Drinker-vs-Weekly Drinker
6.738400E-02
Daily Drinker-vs-Occasional Drinker
9.522200E-03
Daily Drinker-vs-Social Drinker
1.844180E-01
Weekly Drinker-vs-Occasional Drinker
9.133400E-01
Weekly Drinker-vs-Social Drinker
4.449200E-01
Occasional Drinker-vs-Social Drinker
2.007000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.973000E-01
Normal-vs-Grade 2
7.430200E-01
Normal-vs-Grade 3
7.127400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.239600E-03
Grade 1-vs-Grade 3
3.836600E-03
Grade 1-vs-Grade 4
8.973000E-01
Grade 2-vs-Grade 3
4.296400E-01
Grade 2-vs-Grade 4
7.430200E-01
Grade 3-vs-Grade 4
7.127400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.754800E-01
Normal-vs-NonDiabetic
8.611000E-01
Diabetic-vs-NonDiabetic
6.773200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.690400E-01
Normal-vs-NoPancreatitis
9.084000E-01
Pancreatitis-vs-NoPancreatitis
6.372000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.968200E-01
Normal-vs-N1
7.909000E-01
N0-vs-N1
9.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.373800E-01
Normal-vs-TP53-NonMutant
9.460400E-01
TP53-Mutant-vs-TP53-NonMutant
1.939420E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
